Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Change in Intangibles (2017 - 2019)

Amphastar Pharmaceuticals has reported Change in Intangibles over the past 4 years, most recently at $151000.0 for Q1 2019.

  • Quarterly results put Change in Intangibles at $151000.0 for Q1 2019, down 96.57% from a year ago — trailing twelve months through Dec 2025 was $151000.0 (changed N/A YoY), and the annual figure for FY2025 was $2.2 million, changed.
  • Change in Intangibles for Q1 2019 was $151000.0 at Amphastar Pharmaceuticals, down from $4.4 million in the prior quarter.
  • Over the last five years, Change in Intangibles for AMPH hit a ceiling of $4.4 million in Q1 2018 and a floor of $151000.0 in Q1 2019.
  • Median Change in Intangibles over the past 3 years was $1.0 million (2017), compared with a mean of $1.5 million.
  • Biggest five-year swings in Change in Intangibles: skyrocketed 340.0% in 2018 and later crashed 96.57% in 2019.
  • Amphastar Pharmaceuticals' Change in Intangibles stood at $1.0 million in 2017, then surged by 340.0% to $4.4 million in 2018, then crashed by 96.57% to $151000.0 in 2019.
  • The last three reported values for Change in Intangibles were $151000.0 (Q1 2019), $4.4 million (Q1 2018), and $1.0 million (Q3 2017) per Business Quant data.